Taniguchi, H.; Yamanaka, T.; Sakai, D.; Muro, K.; Yamazaki, K.; Nakata, S.; Kimura, H.; Ruff, P.; Kim, T.W.; Peeters, M.;
et al. Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G. Cancers 2020, 12, 1715.
https://doi.org/10.3390/cancers12071715
AMA Style
Taniguchi H, Yamanaka T, Sakai D, Muro K, Yamazaki K, Nakata S, Kimura H, Ruff P, Kim TW, Peeters M,
et al. Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G. Cancers. 2020; 12(7):1715.
https://doi.org/10.3390/cancers12071715
Chicago/Turabian Style
Taniguchi, Hiroya, Takeharu Yamanaka, Daisuke Sakai, Kei Muro, Kentaro Yamazaki, Susumu Nakata, Hiroyuki Kimura, Paul Ruff, Tae Won Kim, Marc Peeters,
and et al. 2020. "Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G" Cancers 12, no. 7: 1715.
https://doi.org/10.3390/cancers12071715
APA Style
Taniguchi, H., Yamanaka, T., Sakai, D., Muro, K., Yamazaki, K., Nakata, S., Kimura, H., Ruff, P., Kim, T. W., Peeters, M., & Price, T.
(2020). Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G. Cancers, 12(7), 1715.
https://doi.org/10.3390/cancers12071715
